TY - JOUR
T1 - Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan
AU - Chiba, N.
AU - Morozumi, M.
AU - Sunaoshi, K.
AU - Takahashi, S.
AU - Takano, M.
AU - Komori, T.
AU - Sunakawa, K.
AU - Ubukata, K.
PY - 2010/1
Y1 - 2010/1
N2 - Invasive pneumococcal disease (IPD) is of concern in Japan, where the heptavalent pneumococcal conjugate vaccine (PCV7) is unavailable. We determined serotypes, genotypes indicating -lactam resistance, and antibiotic susceptibilities of 496 isolates from normally sterile sites in patients (193 children, 303 adults) from 186 institutions between August 2006 and July 2007. Disease presentations included sepsis (462%), pneumonia (315%), and meningitis (175%). Mortality was 14% in children and 221% in adults, many of whom had underlying diseases. In children, serotype 6B (225%) was followed by 19F (141%), and 14 (131%); potential coverages of PCV7 and PCV13 were 754% and 937%, respectively. In adults, serotype 12F (143%) was followed by 3 (113%), and 6B (103%); 23-valent polysaccharide vaccine (PPV23) coverage was 854%. Most serotype 12F strains were gPISP, with pbp2b gene alteration; carbapenem had an excellent MIC90. PCV7 is recommended for children and PPV23 for adults to increase prevention against IPD.
AB - Invasive pneumococcal disease (IPD) is of concern in Japan, where the heptavalent pneumococcal conjugate vaccine (PCV7) is unavailable. We determined serotypes, genotypes indicating -lactam resistance, and antibiotic susceptibilities of 496 isolates from normally sterile sites in patients (193 children, 303 adults) from 186 institutions between August 2006 and July 2007. Disease presentations included sepsis (462%), pneumonia (315%), and meningitis (175%). Mortality was 14% in children and 221% in adults, many of whom had underlying diseases. In children, serotype 6B (225%) was followed by 19F (141%), and 14 (131%); potential coverages of PCV7 and PCV13 were 754% and 937%, respectively. In adults, serotype 12F (143%) was followed by 3 (113%), and 6B (103%); 23-valent polysaccharide vaccine (PPV23) coverage was 854%. Most serotype 12F strains were gPISP, with pbp2b gene alteration; carbapenem had an excellent MIC90. PCV7 is recommended for children and PPV23 for adults to increase prevention against IPD.
KW - Antibiotic resistance
KW - Molecular epidemiology
KW - Streptococcus pneumoniae (pneumococcus)
KW - Surveillance
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=73349139522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73349139522&partnerID=8YFLogxK
U2 - 10.1017/S0950268809990239
DO - 10.1017/S0950268809990239
M3 - Article
C2 - 19538821
AN - SCOPUS:73349139522
SN - 0950-2688
VL - 138
SP - 61
EP - 68
JO - Journal of Hygiene
JF - Journal of Hygiene
IS - 1
ER -
